Botswana launches infant HIV testing program

NewsGuard 100/100 Score

Botswana in a ceremony in Francistown -- attended by Mark Dybul, who serves as the U.S. global AIDS coordinator and administers the President's Emergency Plan for AIDS Relief -- launched a program to test six-month-old infants for HIV, according a U.S. embassy statement released on Wednesday, SAPA/SABC News reports.

The testing program, which aims to monitor infants born to HIV-positive women, facilitates HIV diagnosis in infants six weeks of age and older by using DNA collected through dried blood samples, which do not require refrigeration and can be transported.

According to trials conducted last year by Botusa, a partnership between the Botswana government and CDC, early testing helps control viral loads in HIV-positive infants.

Previously, infants were tested using enzyme-linked immunosorbant assay tests at 18 months, when they already could be at an advanced stage of infection, according to SAPA/SABC.

Pilot programs of the infant testing campaign have been conducted successfully at 11 clinics and one referral hospital in the country, SAPA/SABC News reports.

Botswana is a PEPFAR "focus country" and this year has received $54 million from the program for efforts to combat HIV/AIDS, SAPA/SABC reports (SAPA/SABC, 10/25).

Dybul during his visit to the country said that prevention and behavior change can eliminate the need for antiretroviral treatment.

He added that although there has been progress in the fight against HIV/AIDS, more needs to be done. "AIDS isn't going anywhere," and antiretrovirals are "not a cure," Dybul said (Mmegi/AllAfrica.com, 10/26).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop precise drugs to target HIV's Nef protein